Back
Weyco Group Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
52
WEYS
Weyco Group
Last Price:
$29.13
Seasonality Move:
2.37%
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$53.80
Seasonality Move:
13.2%
Buy
52
Weyco Group (WEYS)
is a Buy
Is Weyco Group a Buy, Sell or Hold?
-
The current Weyco Group [WEYS] share price is $28.97. The Score for WEYS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
WEYS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $53.79. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
WEYS Stock Price Chart
What is Weyco Group's stock price today?
-
The Weyco Group share price today is $28.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WEYS is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $53.79Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
WEYS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.73 | Sell |
Relative Strength Index (14 RSI): | 45.08 | Sell |
Chaikin Money Flow: | 168 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.32 - 30.46) | Sell |
Bollinger Bands (100): | (30.86 - 36.86) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -10.07 | Sell |
Relative Strength Index (14 RSI): | 31.45 | Sell |
Chaikin Money Flow: | -1452145 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.97 - 79.33) | Sell |
Bollinger Bands (100): | (79.54 - 128.22) | Sell |
WEYS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.19 | Sell |
20-day SMA: | 29.37 | Sell |
50-day SMA: | 31.97 | Sell |
200-day SMA: | 33.59 | Sell |
8-day EMA: | 29.07 | Sell |
20-day EMA: | 29.54 | Sell |
50-day EMA: | 31.26 | Sell |
200-day EMA: | 32.79 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.88 | Buy |
20-day SMA: | 60.79 | Sell |
50-day SMA: | 86.36 | Sell |
200-day SMA: | 118.53 | Sell |
8-day EMA: | 54.47 | Sell |
20-day EMA: | 62.27 | Sell |
50-day EMA: | 80.32 | Sell |
200-day EMA: | 108.23 | Sell |
Weyco Group Earnings Growth & WEYS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.
Weyco Group Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |